| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4349510
[patent_doc_number] => 06214788
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-10
[patent_title] => 'Use of cubebol as a flavoring ingredient'
[patent_app_type] => 1
[patent_app_number] => 9/536703
[patent_app_country] => US
[patent_app_date] => 2000-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3008
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/214/06214788.pdf
[firstpage_image] =>[orig_patent_app_number] => 536703
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/536703 | Use of cubebol as a flavoring ingredient | Mar 27, 2000 | Issued |
Array
(
[id] => 1548500
[patent_doc_number] => 06346236
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-02-12
[patent_title] => 'Sunscreens from vegetable oil and plant phenols'
[patent_app_type] => B1
[patent_app_number] => 09/535826
[patent_app_country] => US
[patent_app_date] => 2000-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4269
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/346/06346236.pdf
[firstpage_image] =>[orig_patent_app_number] => 09535826
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/535826 | Sunscreens from vegetable oil and plant phenols | Mar 27, 2000 | Issued |
Array
(
[id] => 1601090
[patent_doc_number] => 06476037
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-05
[patent_title] => 'L-arginine and phosphodiesterase (PDE) inhibitor synergism'
[patent_app_type] => B1
[patent_app_number] => 09/644982
[patent_app_country] => US
[patent_app_date] => 2000-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 21
[patent_no_of_words] => 12448
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/476/06476037.pdf
[firstpage_image] =>[orig_patent_app_number] => 09644982
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/644982 | L-arginine and phosphodiesterase (PDE) inhibitor synergism | Mar 22, 2000 | Issued |
Array
(
[id] => 4379913
[patent_doc_number] => 06303591
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-16
[patent_title] => '21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) and its use as medicament for treating excess of glucocorticoids'
[patent_app_type] => 1
[patent_app_number] => 9/533225
[patent_app_country] => US
[patent_app_date] => 2000-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 18
[patent_no_of_words] => 3760
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/303/06303591.pdf
[firstpage_image] =>[orig_patent_app_number] => 533225
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/533225 | 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) and its use as medicament for treating excess of glucocorticoids | Mar 22, 2000 | Issued |
Array
(
[id] => 5802181
[patent_doc_number] => 20020010148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-24
[patent_title] => 'Oral combinations of hydroxocobalamin and folic acid'
[patent_app_type] => new
[patent_app_number] => 09/534417
[patent_app_country] => US
[patent_app_date] => 2000-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3102
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20020010148.pdf
[firstpage_image] =>[orig_patent_app_number] => 09534417
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/534417 | Oral combinations of hydroxocobalamin and folic acid | Mar 22, 2000 | Issued |
Array
(
[id] => 4321088
[patent_doc_number] => 06248786
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-19
[patent_title] => 'Use of sulphonanilide derivatives to obtain a medicine for treating retrograde ejaculation or aspermia'
[patent_app_type] => 1
[patent_app_number] => 9/508222
[patent_app_country] => US
[patent_app_date] => 2000-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 814
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/248/06248786.pdf
[firstpage_image] =>[orig_patent_app_number] => 508222
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/508222 | Use of sulphonanilide derivatives to obtain a medicine for treating retrograde ejaculation or aspermia | Mar 21, 2000 | Issued |
| 09/509709 | USE OF MOXONIDINE FOR THE TREATMENT OF DEPRESSION | Mar 20, 2000 | Abandoned |
Array
(
[id] => 4421834
[patent_doc_number] => 06225319
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-01
[patent_title] => 'Pesticidal compositions'
[patent_app_type] => 1
[patent_app_number] => 9/531371
[patent_app_country] => US
[patent_app_date] => 2000-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2722
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/225/06225319.pdf
[firstpage_image] =>[orig_patent_app_number] => 531371
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/531371 | Pesticidal compositions | Mar 20, 2000 | Issued |
Array
(
[id] => 4356641
[patent_doc_number] => 06218433
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-17
[patent_title] => 'Use of pharmaceutical composition in the treatment of traumatic arthritis in horses'
[patent_app_type] => 1
[patent_app_number] => 9/446348
[patent_app_country] => US
[patent_app_date] => 2000-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3461
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/218/06218433.pdf
[firstpage_image] =>[orig_patent_app_number] => 446348
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/446348 | Use of pharmaceutical composition in the treatment of traumatic arthritis in horses | Mar 19, 2000 | Issued |
Array
(
[id] => 1550181
[patent_doc_number] => 06346549
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-02-12
[patent_title] => 'Treatment of pharmacology of drug misuse and other addictive disorders'
[patent_app_type] => B1
[patent_app_number] => 09/527726
[patent_app_country] => US
[patent_app_date] => 2000-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2311
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/346/06346549.pdf
[firstpage_image] =>[orig_patent_app_number] => 09527726
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/527726 | Treatment of pharmacology of drug misuse and other addictive disorders | Mar 16, 2000 | Issued |
Array
(
[id] => 4407370
[patent_doc_number] => 06232345
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-15
[patent_title] => 'Cerebral function improving agents'
[patent_app_type] => 1
[patent_app_number] => 9/527241
[patent_app_country] => US
[patent_app_date] => 2000-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 6600
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/232/06232345.pdf
[firstpage_image] =>[orig_patent_app_number] => 527241
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/527241 | Cerebral function improving agents | Mar 16, 2000 | Issued |
Array
(
[id] => 4350535
[patent_doc_number] => 06214851
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-10
[patent_title] => 'N-adamant-1-y1-N1-[4-chlorobenzothiazol-2-y1] urea useful in the treatment of inflammation and as an anticancer radiosensitizing agent'
[patent_app_type] => 1
[patent_app_number] => 9/527331
[patent_app_country] => US
[patent_app_date] => 2000-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5995
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/214/06214851.pdf
[firstpage_image] =>[orig_patent_app_number] => 527331
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/527331 | N-adamant-1-y1-N1-[4-chlorobenzothiazol-2-y1] urea useful in the treatment of inflammation and as an anticancer radiosensitizing agent | Mar 16, 2000 | Issued |
Array
(
[id] => 4359889
[patent_doc_number] => 06191153
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-20
[patent_title] => 'Use of 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazole as a pharmaceutical composition having an antidepressant activity'
[patent_app_type] => 1
[patent_app_number] => 9/526079
[patent_app_country] => US
[patent_app_date] => 2000-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1102
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/191/06191153.pdf
[firstpage_image] =>[orig_patent_app_number] => 526079
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/526079 | Use of 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazole as a pharmaceutical composition having an antidepressant activity | Mar 14, 2000 | Issued |
Array
(
[id] => 4409908
[patent_doc_number] => 06300336
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-09
[patent_title] => 'Method of treating or inhibiting functional disturbances or illnesses of the lower intestinal tracts, particularly abdominal visceral pain which accompanies them'
[patent_app_type] => 1
[patent_app_number] => 9/525896
[patent_app_country] => US
[patent_app_date] => 2000-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2186
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/300/06300336.pdf
[firstpage_image] =>[orig_patent_app_number] => 525896
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/525896 | Method of treating or inhibiting functional disturbances or illnesses of the lower intestinal tracts, particularly abdominal visceral pain which accompanies them | Mar 14, 2000 | Issued |
Array
(
[id] => 4409300
[patent_doc_number] => 06239163
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-29
[patent_title] => 'Salt of (2R,3R,4R)-3,4-dihydroxy-2-hydroxymethylpyrrolidine'
[patent_app_type] => 1
[patent_app_number] => 9/523020
[patent_app_country] => US
[patent_app_date] => 2000-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3392
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/239/06239163.pdf
[firstpage_image] =>[orig_patent_app_number] => 523020
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/523020 | Salt of (2R,3R,4R)-3,4-dihydroxy-2-hydroxymethylpyrrolidine | Mar 9, 2000 | Issued |
Array
(
[id] => 4383963
[patent_doc_number] => 06262085
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-17
[patent_title] => 'Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same'
[patent_app_type] => 1
[patent_app_number] => 9/519976
[patent_app_country] => US
[patent_app_date] => 2000-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24048
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/262/06262085.pdf
[firstpage_image] =>[orig_patent_app_number] => 519976
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/519976 | Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same | Mar 6, 2000 | Issued |
Array
(
[id] => 1565307
[patent_doc_number] => 06376224
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-23
[patent_title] => 'Pharmaceutical compositions for eliminating membrane-mediated cell resistance'
[patent_app_type] => B1
[patent_app_number] => 09/381651
[patent_app_country] => US
[patent_app_date] => 2000-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1978
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/376/06376224.pdf
[firstpage_image] =>[orig_patent_app_number] => 09381651
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/381651 | Pharmaceutical compositions for eliminating membrane-mediated cell resistance | Mar 2, 2000 | Issued |
| 90/005663 | TRIPHASIC ORAL CONTRACEPTIVE | Mar 2, 2000 | Pending |
| 90/005666 | TRIPHASIC ORAL CONTRACEPTIVE | Mar 2, 2000 | Pending |
Array
(
[id] => 1560281
[patent_doc_number] => 06436948
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-20
[patent_title] => 'Method for the treatment of psoriasis and genital warts'
[patent_app_type] => B1
[patent_app_number] => 09/518206
[patent_app_country] => US
[patent_app_date] => 2000-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 10717
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/436/06436948.pdf
[firstpage_image] =>[orig_patent_app_number] => 09518206
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/518206 | Method for the treatment of psoriasis and genital warts | Mar 2, 2000 | Issued |